Intramuscular Injector Market

Intramuscular injector is an injecting device used to delivering medications deep into the muscles. At present, intramuscular injectors are used in modern medicine to enable quick absorption of medication in the bloodstream. Generally, these injectors are used to deliver vaccines and drugs. In addition, these are highly preferred to other drug delivery routes for quick treatment, as muscle tissues have higher blood supply as compared to the tissues present under the skin and muscles are capable of holding high volume of medication.

Intramuscular Injector Market contains market size and forecasts of Intramuscular Injector in global, including the following market information:

Global Intramuscular Injector Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Intramuscular Injector Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Intramuscular Injector companies in 2021 (%)

The global Intramuscular Injector market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Pre-fillable Injection System Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Intramuscular Injector include Antares Pharma, Endo International Plc, Bioject Medical Technologies, PharmaJetMedical International Technology, National Medical Products, Valeritas, European Pharma Group, PenJet Corporation and Becton, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Intramuscular Injector manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Intramuscular Injector Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Intramuscular Injector Market Segment Percentages, by Type, 2021 (%)

Pre-fillable Injection System

Fillable Needle-free Injectors

Global Intramuscular Injector Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Intramuscular Injector Market Segment Percentages, by Application, 2021 (%)

Hospitals

Clinics

Ambulatory Surgery Centers

Others

Global Intramuscular Injector Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Intramuscular Injector Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Intramuscular Injector revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Intramuscular Injector revenues share in global market, 2021 (%)

Key companies Intramuscular Injector sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Intramuscular Injector sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Antares Pharma

Endo International Plc

Bioject Medical Technologies

PharmaJetMedical International Technology

National Medical Products

Valeritas

European Pharma Group

PenJet Corporation

Becton

Dickinson

Injex Pharma AG

Crossject SA

Solace Biotech

Sanify Healthcare Private Limited

Novosanis

Vata

Kaleo